No Data
No Data
Those Who Invested in Imugene (ASX:IMU) Five Years Ago Are up 144%
With Inflation 'Proving Persistent', Is Now Really a Good Time to Buy ASX Tech Shares?
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
Imugene Secures FDA Orphan Drug Designation for Bile Tract Cancer Treatment
Imugene Price Target Cut 33% to A$0.10/Share by Bell Potter
No Data
No Data
151479178 : What are you talking about